1-4 of 4
Melody A. Cobleigh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial

Bryan P. Schneider, Robert J. Gray, Milan Radovich, Fei Shen, Gail Vance, Lang Li, Guanglong Jiang, Kathy D. Miller, Julie R. Gralow, Maura N. Dickler, Melody A. Cobleigh, Edith A. Perez, Tamara N. Shenkier, Kirsten Vang Nielsen, Sven Müller, Ann Thor, George W. Sledge, Jr, Joseph A. Sparano, Nancy E. Davidson, Sunil S. Badve
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1281–1289.
https://doi.org/10.1158/1078-0432.CCR-12-3029
Published: 03 March 2013
View article titled, Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
Open the PDF for Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial in another window
Includes: Supplementary data
Journal Articles

Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer

Adrian M. Jubb, Kathy D. Miller, Hope S. Rugo, Adrian L. Harris, Dafeng Chen, James D. Reimann, Melody A. Cobleigh, Maike Schmidt, Virginia K. Langmuir, Kenneth J. Hillan, Daniel S. Chen, Hartmut Koeppen
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 372–381.
https://doi.org/10.1158/1078-0432.CCR-10-1791
Published: 16 January 2011
View article titled, Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Open the PDF for Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes

Melody A. Cobleigh, Bita Tabesh, Pincas Bitterman, Joffre Baker, Maureen Cronin, Mei-Lan Liu, Russell Borchik, Juan-Miguel Mosquera, Michael G. Walker, Steven Shak
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8623–8631.
https://doi.org/10.1158/1078-0432.CCR-05-0735
Published: 16 December 2005
View article titled, Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes
Open the PDF for Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes in another window
Journal Articles

A Randomized Phase II Feasibility Trial of BMS-275291 in Patients with Early Stage Breast Cancer

Kathy D. Miller, Thomas J. Saphner, David M. Waterhouse, T.-T. Chen, Anita Rush-Taylor, Joseph A. Sparano, Antonio C. Wolff, Melody A. Cobleigh, Susan Galbraith, George W. Sledge
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 1971–1975.
https://doi.org/10.1158/1078-0432.CCR-03-0968
Published: 24 March 2004
View article titled, A Randomized Phase II Feasibility Trial of BMS-275291 in Patients with Early Stage Breast Cancer
Open the PDF for A Randomized Phase II Feasibility Trial of BMS-275291 in Patients with Early Stage Breast Cancer in another window